(VIANEWS) – HCI Group (HCI), BanColombia S.A. (CIB), DexCom (DXCM) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. HCI Group (HCI)
66.8% sales growth and 26.32% return on equity
HCI Group, Inc., together with its subsidiaries, engages in the property and casualty insurance, reinsurance, real estate, and information technology businesses in Florida. It provides residential insurance products, such as homeowners, fire, flood, and wind-only insurance to homeowners, condominium owners, and tenants for properties, as well as offers reinsurance programs. The company also owns and operates waterfront properties and retail shopping centers, and an office building, as well as commercial properties for investment purposes. In addition, it designs and develops web-based applications and products for mobile devices, including SAMS, an online policy administration platform; Harmony, a policy administration platform; ClaimColony, an end-to-end claims management platform; and AtlasViewer, a mapping and data visualization platform. The company was formerly known as Homeowners Choice, Inc. and changed its name to HCI Group, Inc. in May 2013. HCI Group, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.
Earnings Per Share
As for profitability, HCI Group has a trailing twelve months EPS of $7.62.
PE Ratio
HCI Group has a trailing twelve months price to earnings ratio of 14.86. Meaning, the purchaser of the share is investing $14.86 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 26.32%.
Previous days news about HCI Group(HCI)
- HCI group (hci) beats stock market upswing: what investors need to know. According to Zacks on Tuesday, 23 April, "Market participants will be closely following the financial results of HCI Group in its upcoming release. ", "Looking at valuation, HCI Group is presently trading at a Forward P/E ratio of 10.97. "
2. BanColombia S.A. (CIB)
58.7% sales growth and 15.73% return on equity
Bancolombia S. A. provides various banking products and services to individual and corporate customers in Colombia, Panama, Puerto Rico, El Salvador, Costa Rica, and Guatemala. The company operates through nine segments: Banking Colombia, Banking Panama, Banking El Salvador, Banking Guatemala, Trust, Investment Banking, Brokerage, International Banking, and All Other. It offers checking and savings accounts, fixed term deposits, and investment products; trade financing, loans funded by domestic development banks, working capital loans, credit cards, personal and vehicle loans, payroll loans, and overdrafts; financial support to real estate developers and mortgages for individuals and companies; and financial and operating leasing services. The company also provides hedging instruments, including futures, forwards, options, and swaps; and brokerage, investment advisory, and private banking services, including selling and distributing equities, futures, foreign currencies, fixed income securities, mutual funds, and structured products. In addition, it offers cash management services; foreign currency transaction services; life, auto, commercial, and homeowner's insurance products; and online and computer banking services. Further, the company provides investment banking services comprising project and acquisition finance, debt and equity capital markets, principal investments, M&A, restructurings, and structured financing; money market accounts, mutual and pension funds, private equity funds, payment trust, custody, and corporate trust; and digital banking platform, transportation, securities brokerage, maintenance and remodeling, advertising and marketing, and outsourcing services, as well as credit cards. As of December 31, 2020, it operated 1,057 branches; 18,631 banking correspondents; 535 PAMs; 215 kiosks in El Salvador and 137 in Colombia; and 6,124 automatic teller machines. Bancolombia S.A. was incorporated in 1945 and is headquartered in MedellÃn, Colombia.
Earnings Per Share
As for profitability, BanColombia S.A. has a trailing twelve months EPS of $6.49.
PE Ratio
BanColombia S.A. has a trailing twelve months price to earnings ratio of 5.03. Meaning, the purchaser of the share is investing $5.03 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.73%.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Mar 28, 2024, the estimated forward annual dividend rate is 3.65 and the estimated forward annual dividend yield is 11.18%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter is a negative 2.6% and positive 1.4% for the next.
Yearly Top and Bottom Value
BanColombia S.A.’s stock is valued at $32.65 at 06:22 EST, way under its 52-week high of $37.15 and way higher than its 52-week low of $23.12.
Sales Growth
BanColombia S.A.’s sales growth is 61% for the current quarter and 58.7% for the next.
3. DexCom (DXCM)
24.3% sales growth and 25.78% return on equity
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.
Earnings Per Share
As for profitability, DexCom has a trailing twelve months EPS of $1.3.
PE Ratio
DexCom has a trailing twelve months price to earnings ratio of 104.72. Meaning, the purchaser of the share is investing $104.72 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 25.78%.
Previous days news about DexCom(DXCM)
- Dexcom (dxcm) Q1 earnings: how key metrics compare to wall street estimates. According to Zacks on Thursday, 25 April, "For the quarter ended March 2024, DexCom (DXCM Quick QuoteDXCM – Free Report) reported revenue of $921 million, up 24.2% over the same period last year. ", "Here is how DexCom performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:"
4. Lifeway Foods (LWAY)
11.5% sales growth and 21.05% return on equity
Lifeway Foods, Inc. produces and markets probiotic-based products in the United States and internationally. Its primary product is drinkable kefir, a cultured dairy product in various organic and non-organic sizes, flavors, and types. The company also offers European-style soft cheeses; cream and other products; ProBugs, a line of kefir products designed for children; drinkable yogurt; and fresh made butter and sour cream. It sells its products under the Lifeway, Glen Oaks Farms, and Fresh Made brand names, as well as under private labels on behalf of customers primarily through direct sales force, brokers, and distributors. The company was incorporated in 1986 and is based in Morton Grove, Illinois.
Earnings Per Share
As for profitability, Lifeway Foods has a trailing twelve months EPS of $0.75.
PE Ratio
Lifeway Foods has a trailing twelve months price to earnings ratio of 28.03. Meaning, the purchaser of the share is investing $28.03 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 21.05%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 300% and 23.8%, respectively.
Yearly Top and Bottom Value
Lifeway Foods’s stock is valued at $21.02 at 06:22 EST, below its 52-week high of $23.31 and way above its 52-week low of $5.61.
Previous days news about Lifeway Foods(LWAY)
- Lifeway foods (lway) ascends while market falls: some facts to note. According to Zacks on Thursday, 25 April, "Analysts and investors alike will be keeping a close eye on the performance of Lifeway Foods in its upcoming earnings disclosure. ", "Looking at valuation, Lifeway Foods is presently trading at a Forward P/E ratio of 21.43. "
5. Brookfield (BAM)
10% sales growth and 20.63% return on equity
Brookfield Asset Management Ltd. is a real estate investment firm specializing in alternative asset management services. Its renewable power and transition business includes the operates in the hydroelectric, wind, solar, distributed generation, and sustainable solution sector. The company's infrastructure business engages in the utilities, transport, midstream, and data infrastructure sectors. In addition, its private equity business offers industrial, infrastructure, and business services sectors; and real estate business, which includes housing, logistics, hospitality, science and innovation, office, and retail sectors. Further, it provides credit business; and insurance solution in the reinsurance, annuities, operating platform, and investment solutions sectors. Brookfield Asset Management Ltd. was incorporated in 2022 and is headquartered in Toronto, Canada.
Earnings Per Share
As for profitability, Brookfield has a trailing twelve months EPS of $1.13.
PE Ratio
Brookfield has a trailing twelve months price to earnings ratio of 34.85. Meaning, the purchaser of the share is investing $34.85 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.63%.
Yearly Top and Bottom Value
Brookfield’s stock is valued at $39.38 at 06:22 EST, under its 52-week high of $42.86 and way higher than its 52-week low of $28.35.
6. CBOE Holdings (CBOE)
9.7% sales growth and 20.44% return on equity
Cboe Global Markets, Inc., through its subsidiaries, operates as an options exchange worldwide. It operates through five segments: Options, North American Equities, Futures, Europe and Asia Pacific, and Global FX. The Options segment trades in listed market indices. The North American Equities segment trades in listed U.S. and Canadian equities. This segment also offers exchange-traded products (ETP) transaction and ETP listing services. The Futures segment trades in futures. The Europe and Asia Pacific segment offers pan-European listed equities and derivatives transaction services, ETPs, exchange-traded commodities, and international depository receipts, as well as ETP listings and clearing services. The Global FX segment provides institutional foreign exchange (FX) trading and non-deliverable forward FX transactions services. The company has strategic relationships with S&P Dow Jones Indices, LLC; FTSE International Limited; Frank Russell Company; MSCI Inc.; and DJI Opco, LLC. The company was formerly known as CBOE Holdings, Inc. and changed its name to Cboe Global Markets, Inc. in October 2017. Cboe Global Markets, Inc. was founded in 1973 and is headquartered in Chicago, Illinois.
Earnings Per Share
As for profitability, CBOE Holdings has a trailing twelve months EPS of $7.13.
PE Ratio
CBOE Holdings has a trailing twelve months price to earnings ratio of 25.58. Meaning, the purchaser of the share is investing $25.58 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.44%.
Moving Average
CBOE Holdings’s worth is under its 50-day moving average of $185.27 and above its 200-day moving average of $166.79.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 6.8% and 16.3%, respectively.
7. ExlService Holdings (EXLS)
8.8% sales growth and 22.4% return on equity
ExlService Holdings, Inc. operates as a data analytics, and digital operations and solutions company in the United States and internationally. It operates through Insurance, Healthcare, Analytics, and Emerging Business segments. The company provides digital operations and solutions and analytics-driven services across the insurance industry in areas, such as claims processing, premium and benefit administration, agency management, account reconciliation, policy research, underwriting support, new business acquisition, policy servicing, premium audit, surveys, billing and collection, commercial and residential survey, and customer service using digital technology, artificial intelligence, machine learning, and advanced automation; digital customer acquisition services using a software-as-a-service delivery model through LifePRO and LISS platforms; subrogation services; and Subrosource software platform, an end-to-end subrogation platform. It also offers CareRadius, an integrated care management offering; and health care services related to care management, utilization management, disease management, payment integrity, revenue optimization and customer engagement to healthcare payers, providers, pharmacy benefit managers, and life sciences organizations. Further, it offers predictive and prescriptive analytics in the areas of customer acquisition and lifecycle management, risk underwriting and pricing, operational effectiveness, credit and operational risk monitoring and governance, payment integrity and care management, and data management. The company was founded in 1999 and is headquartered in New York, New York.
Earnings Per Share
As for profitability, ExlService Holdings has a trailing twelve months EPS of $1.1.
PE Ratio
ExlService Holdings has a trailing twelve months price to earnings ratio of 26.83. Meaning, the purchaser of the share is investing $26.83 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.4%.
Yearly Top and Bottom Value
ExlService Holdings’s stock is valued at $29.51 at 06:22 EST, way under its 52-week high of $35.94 and way above its 52-week low of $25.17.
Sales Growth
ExlService Holdings’s sales growth is 6.3% for the present quarter and 8.8% for the next.
